Thanks Flex. I really think Denner is very motivated to sell the company sooner vs later and minimize any further risk as anything can potentially go wrong (when it comes to biotech). If he can secure a high 20s bid I think he'll convince the large institutional holders that he should accept!
A win-win today, in the current environment and potential uncertainty in 2017, is a GOOD thing!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.